Cardiovascular Journal of Africa: Vol 31 No 1 (January/February 2020)

17 / 62

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020 AFRICA 15
TheHHAprogrammewasabletodemonstrateanimprovement
in individuals’ knowledge of hypertension within 12 months of
programme implementation. These initial improvements may
eventually lead to longer-term changes in individuals’ attitudes
and behaviours, including lifestyle changes and healthcare-
seeking practices toward hypertension care. Additional studies
are needed to determine realistic time frames for improvements
in lifestyle, regular BP screening, adherence to hypertension care
and reduction in the negative outcomes of hypertension.
The authors thank all the individuals involved with programme implementa-
tion and data collection, field monitoring and data analysis for this study.
We acknowledge the efforts of the HHA partners involved with this study:
Academic Model Providing Access to Healthcare (AMPATH); Amref Health
Africa, formerly African Medical and Research Foundation (AMREF);
Christian Health Association of Kenya (CHAK); Jhpiego; Population
Services Kenya (PSK); Abt Associates; Ipsos Synovate Kenya; and Savannah
Informatics Ltd.
Elizabeth Macgregor-Skinner, formerly of Abt Associates, contributed
to study design and data analysis and interpretation and Doug Johnson,
formerly of Abt Associates, contributed to the study design. The authors
also thank Alec van Gelder, Javier Jimenez, Clive Pickering, Ian MacTavish,
Allan Mackenzie and Kennedy Njau of AstraZeneca, for their support of the
Healthy Heart Africa programme and this study, and Mary Beth DeYoung
of AstraZeneca for providing critical review of the manuscript. Disha Patel,
PhD, of inScience Communications, Springer Healthcare (Philadelphia, PA,
USA), provided medical writing support, which was funded by AstraZeneca.
This study/analysis was funded by AstraZeneca. GY and ENO have
served as consultants for Abt Associates. GY is currently a visiting professor
at the University of Nairobi, Kenya. FOO was an employee of Abt Associates
at the time of the survey and is currently serving as the chief of party for the
US Agency for International Development Ethiopia Performance Monitoring
and Evaluation Service Activity. JLH is an employee of Abt Associates. AM
is an employee of AstraZeneca and has stock/stock options in AstraZeneca.
References
1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et
al. Global disparities of hypertension prevalence and control. A system-
atic analysis of population-based studies from 90 countries. Circulation
2016; 134(6): 441–450.
2. Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK, et al.
Prevalence of hypertension and associated cardiovascular risk factors
in an urban slum in Nairobi, Kenya: a population-based survey. BMC
Public Health 2014; 14: 1177.
3. Van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C.
Prevalence, awareness, treatment and control of hypertension among
slum dwellers in Nairobi, Kenya. J Hypertens 2013; 31(5): 1018–1024.
4. Kenyan Ministry of Health. Kenya STEPwise survey for non-communi-
cable diseases risk factors 2015 report. Nairobi, Kenya. 2015. http://www.
Accessed May 31, 2017.
5. Republicof Kenya.Kenyanationalstrategyforthepreventionandcontrol
of non-communicable diseases. 2015.
uploads/2015/08/Kenya-national-strategy-for-NCDs-2015-2020.pdf.
Accessed May 31, 2017.
6. Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer
IH, et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in
four rural and urban communities. PLoS One 2012; 7(3): e32638.
7. Ogola EN, Okello FO, Herr JL, Macgregor-Skinner E, Mulvaney A,
Yonga G. Healthy Heart Africa – Kenya: a 12-month prospective evalu-
ation of program impact on health care providers’ knowledge and treat-
ment of hypertension. Global Heart. 2019; 14(1): 61–70.
8. Williamson T, Mulaki A. Devolution of Kenya’s health system. The role
of Health Policy Project. Health Policy Project, Washington, DC. 2015.
pdf. Accessed May 31, 2017.
9. Van de Vijver S, Akinyi H, Oti S, Olajide A, Agyemang C, Aboderin I,
et al. Status report on hypertension in Africa –consultative review for the
6th Session of the African Union Conference of Ministers of Health on
NCDs. Pan Afr Med J 2013; 16: 38.
10. Bloomfield GS, Mwangi A, Chege P, Simiyu CJ, Aswa DF, Odhiambo D,
et al. Multiple cardiovascular risk factors in Kenya: evidence from a health
and demographic surveillance system using the WHO STEPwise approach
to chronic disease risk factor surveillance. Heart 2013; 99(18): 1323–1329.
11. Temu TM, Bahiru E, Bukachi F, Bloomfield GS, Muiruri P, Farquhar
C. Lay beliefs about hypertension among HIV-infected adults in Kenya.
Open Heart 2017; 4(1): e000570.
12. Boateng D, Wekesah F, Browne JL, Agyemang C, Agyei-Baffour P,
Aikins Ad-G, et al. Knowledge and awareness of and perception
towards cardiovascular disease risk in sub-Saharan Africa: a systematic
review. PLoS One 2017; 12(12): e0189264.
Online survey:
Supplement.pdf